Literature DB >> 27127222

Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts.

Costanza Santini1, Joeri Kuil2, Anton Bunschoten2, Stefan Pool3, Erik de Blois3, Yanto Ridwan4, Jeroen Essers5, Monique R Bernsen3, Fijs W B van Leeuwen2, Marion de Jong3.   

Abstract

UNLABELLED: In the treatment of neuroendocrine tumors (NETs), complete surgical removal of malignancy is generally desirable, because it offers curative results. Preoperative guidance with radiolabeled somatostatin analogs, commonly used for NET diagnosis and preoperative planning, is limited by its low resolution, with the risk that tumor margins and small metastases will be incompletely resected with subsequent recurrence. A single hybrid probe combining radiotracer and optical dye would enable high-resolution optical guidance, also during surgery. In the current study, the hybrid labeled somatostatin analog Cy5-DTPA-Tyr(3)-octreotate (DTPA is diethylene triamine pentaacetic acid) was synthesized and evaluated for its ability to specifically trace NET cells in vitro and in an animal model. The performance of the hybrid tracer was compared with that of octreotate with only radiolabel or only optical label.
METHODS: The binding affinity and internalization capacity of Cy5-DTPA-Tyr(3)-octreotate were assessed in vitro. Biodistribution profiles and both nuclear and optical in vivo imaging of Cy5-(111)In -DTPA-Tyr(3)-octreotate were performed in NET-bearing mice and compared with the performance of (111)In-DTPA-Tyr(3)-octreotate.
RESULTS: In vitro studies showed a low receptor affinity and internalization rate for Cy5-DTPA-Tyr(3)-octreotate. The dissociation constant value was 387.7 ± 97.9 nM for Cy5-DTPA-Tyr(3)-octreotate, whereas it was 120.5 ± 18.1 nM for DTPA-Tyr(3)-octreotate. Similarly, receptor-mediated internalization reduced from 33.76% ± 1.22% applied dose for DTPA-Tyr(3)-octreotate to 1.32% ± 0.02% applied dose for Cy5-DTPA-Tyr(3)-octreotate. In contrast, in vivo and ex vivo studies revealed similar tumor uptake values of Cy5-(111)In-DTPA-Tyr(3)-octreotate and (111)In -DTPA-Tyr(3)-octreotate (6.93 ± 2.08 and 5.16 ± 1.27, respectively). All organs except the kidneys showed low background radioactivity, with especially low activities in the liver, and high tumor-to-tissue ratios were achieved-both favorable for the tracer's toxicity profile. Hybrid imaging in mice confirmed that the nuclear and fluorescence signals colocalized.
CONCLUSION: The correlation between findings with the optical and the nuclear probes underlines the potential of combining SPECT imaging with fluorescence guidance and shows the promise of this novel hybrid peptide for preoperative and intraoperative imaging of NET.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  image-guided surgery; multimodal imaging; neuroendocrine tumors; octreotate

Mesh:

Substances:

Year:  2016        PMID: 27127222     DOI: 10.2967/jnumed.115.164970

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  Synthesis of a Fluorescently Labeled 68Ga-DOTA-TOC Analog for Somatostatin Receptor Targeting.

Authors:  Sukhen C Ghosh; Servando Hernandez Vargas; Melissa Rodriguez; Susanne Kossatz; Julie Voss; Kendra S Carmon; Thomas Reiner; Agnes Schonbrunn; Ali Azhdarinia
Journal:  ACS Med Chem Lett       Date:  2017-06-06       Impact factor: 4.345

2.  A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting.

Authors:  Sukhen C Ghosh; Melissa Rodriguez; Kendra S Carmon; Julie Voss; Nathaniel L Wilganowski; Agnes Schonbrunn; Ali Azhdarinia
Journal:  J Nucl Med       Date:  2017-06-01       Impact factor: 10.057

3.  Specific Targeting of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery.

Authors:  Servando Hernandez Vargas; Susanne Kossatz; Julie Voss; Sukhen C Ghosh; Hop S Tran Cao; Jo Simien; Thomas Reiner; Sadhna Dhingra; William E Fisher; Ali Azhdarinia
Journal:  Clin Cancer Res       Date:  2019-04-23       Impact factor: 12.531

4.  Necrosis binding of Ac-Lys0(IRDye800CW)-Tyr3-octreotate: a consequence from cyanine-labeling of small molecules.

Authors:  Marcus C M Stroet; Bianca M Dijkstra; Sebastiaan E Dulfer; Schelto Kruijff; Wilfred F A den Dunnen; Frank A E Kruyt; Rob J M Groen; Yann Seimbille; Kranthi M Panth; Laura Mezzanotte; Clemens W G M Lowik; Marion de Jong
Journal:  EJNMMI Res       Date:  2021-05-10       Impact factor: 3.138

5.  Evaluation of Ac-Lys0(IRDye800CW)Tyr3-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma.

Authors:  Frank A E Kruyt; Rob J M Groen; Bianca M Dijkstra; Marion de Jong; Marcus C M Stroet; Fritz Andreae; Sebastiaan E Dulfer; Marieke Everts; Schelto Kruijff; Julie Nonnekens; Wilfred F A den Dunnen
Journal:  J Neurooncol       Date:  2021-03-26       Impact factor: 4.130

6.  Generation of fluorescently labeled tracers - which features influence the translational potential?

Authors:  Fijs W B van Leeuwen; Bart Cornelissen; Federico Caobelli; Laura Evangelista; Latifa Rbah-Vidal; Silvana Del Vecchio; Catarina Xavier; Jacques Barbet; Marion de Jong
Journal:  EJNMMI Radiopharm Chem       Date:  2017-12-15

Review 7.  Hybrid intraoperative imaging techniques in radioguided surgery: present clinical applications and future outlook.

Authors:  S L Bugby; J E Lees; A C Perkins
Journal:  Clin Transl Imaging       Date:  2017-06-27

8.  A Cyanine-Bridged Somatostatin Hybrid Probe for Multimodal SSTR2 Imaging in Vitro and in Vivo: Synthesis and Evaluation.

Authors:  Isabelle Heing-Becker; Carsten Grötzinger; Nicola Beindorff; Sonal Prasad; Sarah Erdmann; Samantha Exner; Rainer Haag; Kai Licha
Journal:  Chembiochem       Date:  2021-01-04       Impact factor: 3.164

Review 9.  Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives.

Authors:  Manja Kubeil; Irma Ivette Santana Martínez; Michael Bachmann; Klaus Kopka; Kellie L Tuck; Holger Stephan
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-31

Review 10.  How molecular imaging will enable robotic precision surgery : The role of artificial intelligence, augmented reality, and navigation.

Authors:  Thomas Wendler; Fijs W B van Leeuwen; Nassir Navab; Matthias N van Oosterom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-29       Impact factor: 9.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.